Well Health Provides Vague Preliminary Q4 Results, Announces Return Of Buyback Program
Well Health (TSX: WELL) is looking to boost its share price. The firm this morning published preliminary earnings for the
Read moreWell Health (TSX: WELL) is looking to boost its share price. The firm this morning published preliminary earnings for the
Read moreToday on the Daily Dive, we are joined by George Adams, Chairman of Ventripoint Diagnostics (TSXV: VPT). George joins us
Read moreDatametrex AI (TSXV: DM) is expected to see its health division grow as a result of the exploding cases of
Read moreIt appears the outright embarrassing events over at Telecure Technologies (CSE: TELE) have finally come to a head. The firm
Read moreMind Medicine (NEO: MMED) appears to now be fully under new management. On Friday evening, after the close of markets,
Read moreEmpower Clinics (CSE: CBDT) has evidently closed a much-needed financing as of last night. The financing consisted of both units
Read moreIt was a rather eventful evening for dentalcorp (TSX: DNTL) last night, whom announced a large bought deal financing, while
Read moreKetamineOne Capital (NEO: MEDI) released this morning its financial reports for the fiscal quarter ended October 31, 2021. The firm managed
Read moreCognetivity Neurosciences (CSE: CGN) is looking to close out the year with a capital raise. The firm last night indicated
Read moreDatametrex AI (TSXV: DM) continues to develop out its healthcare division focused on COVID-19 testing. The firm this morning revealed
Read more